Saturday, May 25, 2013
Membership
Total Users
- 40059 registered
- 7 today
- 261 this week
- 5132 this month
- Last: Debra
Carboplatin
-
Alterations of Intratumoral Pharmacokinetics of 5-Fluorouracil in Head and Neck Carcinoma during ...

- Date Added:
- 02/11/2009
- Hits:
- 0
The kinetics of local drug uptake and metabolism of the anticancer drug 5-fluorouracil (5-FU) has been monitored by means of 19F nuclear magnetic resonance spectroscopy in 17 patients with neck tumors during concurrent radiochemotherapy. All of the patients underwent an accelerated hyperfractionated, concomitant-boost radiochemotherapy with 5-FU[600 or 1000 mg/m2 of body surface (b.s.)] and carboplatin (70 mg/m2 of b.s.). -
BCCA Protocol Summary for Combined Chemotherapy (Carboplatin and Fluorouracil)

- Date Added:
- 02/11/2009
- Hits:
- 0
EXCLUSIONS:Prior chemotherapy or radiotherapy to the head and neck region.Neutropenia, absolute neutrophil count < 1.5 x 109/L. Thrombocytopenia, platelet count < 100 x 109/L. Renal insufficiency with creatinine > 120 mmol/L or Creatinine clearance £ 50 mL/min.Bilirubin > 1.5 x upper limit of normal -
Carboplatin

- Date Added:
- 02/11/2009
- Hits:
- 0
Carboplatin is a cisplatin derivative and shares the same mechanism of action. Highly reactive platinum complexes are formed intracellularly. These complexes inhibit DNA synthesis through covalent binding of DNA molecules to form intrastrand and interstrand DNA ross-links. Carboplatin is considered to be cell cycle phase-nonspecific, but recent studies have shown complex and variable effects on the cell cycle.
-
Carboplatin Chemotherapy for Progressive Intramedullary Spinal Cord Low-grade Gliomas in...

- Date Added:
- 02/11/2009
- Hits:
- 0
CNS tumors account for at least 20% of all childhood malignancies and are the second most common after leukemia (Cokgor et al., 1998; Lowis et al., 1998; Stiller and Nectoux, 1994). Only 2% to 10% of these tumors are intramedullary spinal cord tumors (Allen et al., 1998; Bouffet et al., 1997; Chun et al., 1990; Constantini et al., 1996; Lowis et al., 1998; Nadkarni and Rekate, 1999; Rossitch et al., 1990; Stiller and Nectoux, 1994). -
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated ...

- Date Added:
- 02/11/2009
- Hits:
- 0
Radiation therapy (RT) alone cures approximately 10% and 25% of patients with locally advanced and medically unresectable non–small-cell lung cancer (NSCLC), respectively.1-5 The addition of equential 5-10 or concurrent chemotherapy11,12 with de?nitive RT modestly improves survival. Concurrent chemotherapy appears more ef?cacious than sequential therapy.13,14 High-dose 6,15-20 and/or intensi?ed/shortened21, 22 RT programs have been proposed.
